Home Podcasts The Lancet Microbe in conversation with
The Lancet Microbe in conversation with

The Lancet Microbe in conversation with

The Lancet Group 26 Episodes Jun 24, 2026

Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.

Episodes

Antimicrobial resistance National Action Plans and the role of microbial genomics with with Kate Baker and Tess Johnson Jun 24, 2026 2033 In this episode, we discuss antimicrobial resistance (AMR) priorities, as outlined in the UK National Action Plan (NAP) for AMR, and how microbial genomics can contribute to meeting them in the UK and beyond. Guests Kate Baker, a researcher at the Department of Genetics, University of Cambridge (Cambridge, UK) and Tess Johnson, a bioethicist at the Ethox Centre of the University of Oxford (Oxford,
Henriette Nielsen on vaginal microbiota transplantation May 25, 2026 1013 Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.” Together, they explore the study’s key findings, its implications for women’s health, and the growing importanc
Zakiul Hassan and Tahmina Shirin on Nipah virus disease Apr 13, 2026 2221 Phoebe Ashley-Norman talks with Zakiul Hassan and Prof Tahmina Shirin about the findings of "Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review", by Zakiul Hassan and colleagues. We also discuss Nipah virus disease more broadly, talking about recent phylogenetic findings, diagnostics, therapeutics, va
Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing Mar 5, 2026 2204 Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and p
Magnus Unemo on Zoliflodacin treatment for gonorrhea Feb 5, 2026 967 Elisa Pucu from The Lancet Microbe interviews Dr. Magnus Unemo of Örebro University about the clinical implications and key findings from his research. They discuss about the the microbiological analysis and whole genome sequencing of treatment failures from the zoliflodacin phase 3 clinical trial for gonorrhea—revealing insights that could change the future of treatment and antibiotic resistance.
Amber Barton on mass drug administration to eradicate yaws in Papua New Guinea Jan 6, 2026 1294 Phoebe Ashley-Norman of The Lancet Microbe speaks to Amber Barton about the neglected tropical disease, yaws. Efforts to eradicate yaws were first made in the 1950s through a WHO and UNICEF campaign that reduced yaws prevalence by 90%, but it remained endemic in some regions.  Global efforts involving the mass drug administration of azithromycin continue in pursuit of the WHO 2030 yaws eradication
Britt Koskella on bacteriophages as a signature of microbiome health Dec 22, 2025 1673 Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Britt Koskella about bacteriophages and phageome, their role in modulating the bacteriome, their potential use as signatures of microbiome health and dysbiosis, and hence, indirectly, as markers of host health and disease status.  From an ecological perspective, parasites (such as bacteriophages) are key drivers of the evolution of their hosts
Christian Malaka and Livia Patrono on the surveillance of mpox in the Central African Republic Nov 3, 2025 2028 Rebecca Barksby of The Lancet Microbe speaks to Dr Christian Malaka and Dr Livia Patrono on mpox in the Central African Republic and how researchers are using genomic surveillance to provide insights into the epidemiology of the virus. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00101-6/fulltext Continue this conversation on social! Follow us today at.
Sam Lipworth and Nicole Stoesser on genotypic and phenotypic antimicrobial resistance in Escherichia coli Oct 7, 2025 1546 Elena Dalla Vecchia talks with Dr Sam Lipworth and Prof Nicole Stoesser about the challenges and variability in genotypic predictions of antimicrobial resistance in Escherichia coli, about which they have published two papers in The Lancet Microbe: “Exploring uncatalogued genetic variation in antimicrobial resistance gene families in Escherichia coli: an observational analysis” and “Estimating the
Anastasia Theodosiou on controlled human infection with Neisseria lactamica in pregnancy Apr 1, 2025 1806 Rebecca Barksby of The Lancet Microbe speaks to Dr Anastasia Theodosiou about performing a controlled human infection study in pregnant women investigating mother-to-infant transmission of Neisseria lactamica. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00254-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! F
Susan Meiring, Vanessa Quan, and Nelesh Govender on bloodstream infections in neonates in South Africa Feb 25, 2025 1542 Elena Dalla Vecchia of The Lancet Microbe speaks to Susan Meiring, Vanessa Quan, and Nelesh Govender about bloodstream infections in neonates at lower-tier South African hospitals. Read the full paper, Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study, at https://www.thelancet.com/journals/lanmic/
Laurence Armand-Lefevre and Luc Samison on surveillance of antimicrobial resistant Escherichia coli in humans, chickens, and the environment in Madaga... Aug 5, 2024 1600 Rebecca Barksby of The Lancet Microbe speaks to Professor Laurence Armand-Lefevre and Professor Luc Hervé Samison about implementing the WHO Tricycle Protocol in Madagascar for the surveillance of extended-spectrum β-lactamase producing Escherichia coli in humans, chickens, and the environment. Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00228-1/fullt

Recommended